Cargando…
Virus-Like Particles, a Versatile Subunit Vaccine Platform
Virus-like particles (VLPs) can be spontaneously formed after expression of self-polymerising viral capsid proteins. VLPs structurally resemble their native source virus, maintaining immunological relevance by retaining formation of immunogenic motifs with natural conformation. The absence of the vi...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7121566/ http://dx.doi.org/10.1007/978-1-4939-1417-3_9 |
_version_ | 1783515231029297152 |
---|---|
author | Donaldson, Braeden Al-Barwani, Farah Young, Vivienne Scullion, Sarah Ward, Vernon Young, Sarah |
author_facet | Donaldson, Braeden Al-Barwani, Farah Young, Vivienne Scullion, Sarah Ward, Vernon Young, Sarah |
author_sort | Donaldson, Braeden |
collection | PubMed |
description | Virus-like particles (VLPs) can be spontaneously formed after expression of self-polymerising viral capsid proteins. VLPs structurally resemble their native source virus, maintaining immunological relevance by retaining formation of immunogenic motifs with natural conformation. The absence of the virus genome renders VLPs safe for administration as a subunit vaccine. VLPs can target both arms of the immune response, with some VLPs initiating production of specific antibodies and others activating cytotoxic T cells. VLPs are also exceptionally versatile, conferring protection against the host virus or acting as a scaffold for antigenic molecules. In addition, VLP can support intraparticulate encapsulation for immunomodulation and gene delivery. VLP vaccines have been developed for prophylactic protection against infectious organisms, and therapeutic treatment of conditions such as Alzheimer’s disease, hypertension, and cancer. With an expanding list of vaccine candidates, VLP vaccines are a promising field with a wide range of applications. |
format | Online Article Text |
id | pubmed-7121566 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
record_format | MEDLINE/PubMed |
spelling | pubmed-71215662020-04-06 Virus-Like Particles, a Versatile Subunit Vaccine Platform Donaldson, Braeden Al-Barwani, Farah Young, Vivienne Scullion, Sarah Ward, Vernon Young, Sarah Subunit Vaccine Delivery Article Virus-like particles (VLPs) can be spontaneously formed after expression of self-polymerising viral capsid proteins. VLPs structurally resemble their native source virus, maintaining immunological relevance by retaining formation of immunogenic motifs with natural conformation. The absence of the virus genome renders VLPs safe for administration as a subunit vaccine. VLPs can target both arms of the immune response, with some VLPs initiating production of specific antibodies and others activating cytotoxic T cells. VLPs are also exceptionally versatile, conferring protection against the host virus or acting as a scaffold for antigenic molecules. In addition, VLP can support intraparticulate encapsulation for immunomodulation and gene delivery. VLP vaccines have been developed for prophylactic protection against infectious organisms, and therapeutic treatment of conditions such as Alzheimer’s disease, hypertension, and cancer. With an expanding list of vaccine candidates, VLP vaccines are a promising field with a wide range of applications. 2014-08-28 /pmc/articles/PMC7121566/ http://dx.doi.org/10.1007/978-1-4939-1417-3_9 Text en © Springer Science+Business Media New York 2015 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Article Donaldson, Braeden Al-Barwani, Farah Young, Vivienne Scullion, Sarah Ward, Vernon Young, Sarah Virus-Like Particles, a Versatile Subunit Vaccine Platform |
title | Virus-Like Particles, a Versatile Subunit Vaccine Platform |
title_full | Virus-Like Particles, a Versatile Subunit Vaccine Platform |
title_fullStr | Virus-Like Particles, a Versatile Subunit Vaccine Platform |
title_full_unstemmed | Virus-Like Particles, a Versatile Subunit Vaccine Platform |
title_short | Virus-Like Particles, a Versatile Subunit Vaccine Platform |
title_sort | virus-like particles, a versatile subunit vaccine platform |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7121566/ http://dx.doi.org/10.1007/978-1-4939-1417-3_9 |
work_keys_str_mv | AT donaldsonbraeden viruslikeparticlesaversatilesubunitvaccineplatform AT albarwanifarah viruslikeparticlesaversatilesubunitvaccineplatform AT youngvivienne viruslikeparticlesaversatilesubunitvaccineplatform AT scullionsarah viruslikeparticlesaversatilesubunitvaccineplatform AT wardvernon viruslikeparticlesaversatilesubunitvaccineplatform AT youngsarah viruslikeparticlesaversatilesubunitvaccineplatform |